SCHEMBL27034795

SCHEMBL27034795

CC(C)(C)OC(=O)N1C[C@]2(C[C@H]1C(N)=O)C(=O)Nc1ccc(Br)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 5/20 0.39
▸ RXRA P19793 4/20 0.39
▸ NR1H3 Q13133 4/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ CCNB2 O95067 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ CCNB3 Q8WWL7 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ RORC P51449 2/20 0.35
▸ KCNT1 Q5JUK3 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ F2 P00734 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29616596 1.00 NR1H2 (0.39) NR1H2RXRANR1H3L3MBTL1GAA
SCHEMBL30917881 1.00 NR1H2 (0.39) NR1H2RXRANR1H3L3MBTL1GAA
SCHEMBL27034709 0.92 NR1H2 (0.37) NR1H2RXRANR1H3L3MBTL1GAA
SCHEMBL24446810 0.89 IMPDH2 (0.40) NR1H2RXRANR1H3L3MBTL1GAA
SCHEMBL31036479 0.88 NR1H2 (0.39) NR1H2RXRANR1H3KMT2ACYP1A2
SCHEMBL24451644 0.88 IP6K1 (0.40) NR1H2RXRANR1H3MEN1ALDH1A1
SCHEMBL24454023 0.88 IP6K1 (0.40) NR1H2RXRANR1H3MEN1ALDH1A1
SCHEMBL24403239 0.86 NR1H2 (0.48) NR1H2RXRANR1H3
SCHEMBL30599282 0.86 NR1H2 (0.48) NR1H2RXRANR1H3
SCHEMBL24403238 0.86 NR1H2 (0.48) NR1H2RXRANR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118986968-A Pharmaceutical composition of 3CL inhibitor compound and application thereof 深圳信立泰药业股份有限公司 2024-11-22 — — CN disclosed
CN-118146228-A Deuterated spiro compound crystal form and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-06-07 — — CN disclosed
WO-2024017270-A1 SPIRO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳信立泰药业股份有限公司 2024-01-25 — — WO disclosed
CN-116621918-B Spiro compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2023-10-31 — — CN disclosed
CN-116621918-A Spiro compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2023-08-22 — — CN disclosed
Send feedback